Paper
8 January 2024 Existing problems and improving methods of CAR-T therapy
Yumeng Li
Author Affiliations +
Proceedings Volume 12924, Third International Conference on Biological Engineering and Medical Science (ICBioMed2023); 129241M (2024) https://doi.org/10.1117/12.3012990
Event: 3rd International Conference on Biological Engineering and Medical Science (ICBioMed2023), 2023, ONLINE, United Kingdom
Abstract
Myxobacteria is a kind of gram-negative bacteria. As higher prokaryotes, myxobacteria is widely distributed, and it can glide and prey on other bacteria. Myxobacteria have many species and can live in various extreme environments. Due to its special predation characteristics and abundant secondary metabolites, more and more researchers have paid attention to it in recent years. According to these characteristics, myxobacteria have been widely used in agricultural disease prevention and control, medical disease research, food safety and preservation, environmental management and protection, etc. However, because the current technical means are not enough to excavate all kinds of myxobacteria species, the research on their separation and classification is still slow. This thesis summarizes the methods and status quo of myxobacteria isolation and identification in recent years, research progress on predation and secondary metabolites of myxobacteria in different disciplines and fields. On this basis, the bottleneck of myxobacteria research and its future prospects are put forward.
(2024) Published by SPIE. Downloading of the abstract is permitted for personal use only.
Yumeng Li "Existing problems and improving methods of CAR-T therapy", Proc. SPIE 12924, Third International Conference on Biological Engineering and Medical Science (ICBioMed2023), 129241M (8 January 2024); https://doi.org/10.1117/12.3012990
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Cancer

Neurotoxicity

Tumors

Chromium

Oncology

Proteins

Clinical trials

Back to Top